Publications by authors named "Srujan Reddy"
Arab J Gastroenterol
February 2024
Article Synopsis
- Tuberculosis (TB) is a significant risk for patients with autoimmune diseases receiving anti-TNF therapies, particularly in TB-endemic countries like India, and this study focuses on understanding this risk in patients with inflammatory bowel disease (IBD).
- The study analyzed data from 95 IBD patients treated with anti-TNF agents, primarily infliximab, over a median follow-up of 9 months, finding that 8.4% developed TB, mostly extrapulmonary cases.
- The duration of anti-TNF therapy emerged as the sole independent predictor for TB development, highlighting limitations in current latent TB screening methods in India and the challenges of predicting TB in these patients.
